From the end of the 2000s, after the introduction of the first antiretroviral therapies (ART), it became clear that the benefits of these treatments were considerably greater than their side effects, especially when introduced early. The recommendation at present is to begin treatment with ART as soon as CD4 T-cell count falls below the normal level of 500/mm3.
Private long-term care insurance (LTCI) is now in its fourth decade - the last, in the view of some, in which it will be sold widely across America. Before we observe the obsequies, it may be well to take stock of where we actually are, because sales of stand-alone LTCI products - not to mention linked or combination products, chronic illness coverage, and short-term care insurance - do take place each day, suggesting that private LTCI is filling a need.
Hybrid life insurance/long-term care product sales are rising, but the industry must pay attention to pricing and risk mitigation techniques.